199
Views
31
CrossRef citations to date
0
Altmetric
Review

Coronary stents and vascular response to implantation: literature review

, , , , &
Pages 137-148 | Published online: 13 Jul 2017

References

  • SerruysPWRutherfordJDThe birth, and evolution, of percutaneous coronary interventions: a conversation with Patrick Serruys, MD, PhDCirculation20161349710027400895
  • LiistroFStankovicGDi MarioCFirst clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcomeCirculation20021051883188611997271
  • FinnAVNakazawaGJonerMVascular responses to drug eluting stents: importance of delayed healingArterioscler Thromb Vasc Biol2007271500151017510464
  • ChenMSJohnJMChewDPLeeDSEllisSGBhattDLBare metal stent restenosis is not a benign clinical entityAm Heart J20061511260126416781233
  • JaffeRStraussBHLate and very late thrombosis of drug-eluting stents: evolving concepts and perspectivesJ Am Coll Cardiol20075011912717616295
  • PratiFRegarEMintzGSExpert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosisEur Heart J20103140141519892716
  • PratiFGuagliumiGMintzGSExpert review document part 2: methodology, terminology, and clinical applications of optical coherence tomography for the assessment of interventional proceduresEur Heart J2012332513252022653335
  • TearneyGJRegarEAkasakaTConsensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validationJ Am Coll Cardiol2012591058107222421299
  • Di VitoLYoonJHKatoKComprehensive overview of definitions for optical coherence tomography-based plaque and stent analysesCoron Artery Dis20142517218524356250
  • HasegawaKTamaiHKyoEHistopathological findings of new in-stent lesions developed beyond five yearsCatheter Cardiovasc Interv20066855455816969849
  • NakazawaGVorpahlMFinnAVNarulaJVirmaniROne step forward and two steps back with drug-eluting stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosisJACC Cardiovasc Imaging20092562562819442951
  • NakazawaGOtsukaFNakanoMThe pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stentsJ Am Coll Cardiol2011571314132221376502
  • GruntzigARSenningASiegenthalerWENonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplastyN Engl J Med19793016168449946
  • SigwartUPuelJMirkovitchVJoffreFKappenbergerLIntravascular stents to prevent occlusion and restenosis after transluminal angioplastyN Engl J Med19873167017062950322
  • SerruysPWde JaegerePKiemeneijFA comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery diseaseN Engl J Med19943314894958041413
  • FischmanDLLeonMBBaimDSA randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery diseaseN Engl J Med19943314965018041414
  • SchomigANeumannFJKastratiAA randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsN Engl J Med1996334108410898598866
  • ColomboAHallPNakamuraSIntracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidanceCirculation199591167616887882474
  • SousaJECostaMAAbizaidALack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound studyCirculation200110319219511208675
  • PfistererMBrunner-La RoccaHPBuserPTLate clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stentsJ Am Coll Cardiol2006482584259117174201
  • CamenzindEStegPGWijnsWStent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernCirculation20071151440145517344324
  • KereiakesDJCoxDAHermillerJBUsefulness of a cobalt chromium coronary stent alloyAm J Cardiol20039246346612914881
  • SousaJECostaMAAbizaidACSustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-upCirculation20011042007201111673337
  • MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med20023461773178012050336
  • StoneGWEllisSGCannonLComparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trialJAMA20052941215122316160130
  • DawkinsKDGrubeEGuagliumiGClinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practiceCirculation20051123306331316286586
  • KastratiADibraAEberleSSirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trialsJAMA200529481982516106007
  • SchomigADibraAWindeckerSA meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery diseaseJ Am Coll Cardiol2007501373138017903638
  • KereiakesDJCannonLAFeldmanRLClinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (prospective evaluation in a randomized trial of the safety and efficacy of the use of the TAXUS Element paclitaxel-eluting coronary stent system) trialJ Am Coll Cardiol20105626427120493653
  • KandzariDELeonMBPopmaJJComparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease. A randomized controlled trialJ Am Coll Cardiol2006482440244717174180
  • LeonMBNikolskyECutlipDEImproved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (randomized comparison of zotarolimus-and paclitaxel-eluting stents in patients with coronary artery disease) trialJACC Cardiovasc Interv201031043105020965463
  • CamenzindEWijnsWMauriLStent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trialLancet20123801396140522951082
  • TaniwakiMStefaniniGGSilberS4-Year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)J Am Coll Cardiol2014631617162524530680
  • SerruysPWSilberGGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med201036313614620554978
  • SerruysPWOngATPiekJJA randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trialEurointervention20051586519758878
  • SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialEurointervention2006228629419755303
  • StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA20082991903191318430909
  • ParkKWChaeIHLimDSEverolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (efficacy of Xience/Primus versus Cypher to reduce late loss after stenting) randomized trialJ Am Coll Cardiol2011581844185422018294
  • SabateMCequierAIñiguezAEverolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomized controlled trialLancet20123801482149022951305
  • BeijkMAKlompMVeroudenNJGenous endothelial progenitor cell capturing stent vs the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot studyEur Heart J2010311055106419933225
  • NatsuakiMKozumaKMorimotoTFinal 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trialCirc Cardiovasc Interv20158e00281726446596
  • UrbanPMeredithITAbizaidAPolymer-free drug-coated coronary stents in patients at high bleeding riskN Engl J Med20153732038204726466021
  • DudekDOnumaYOrmistonJAThuesenLMiquel-HébertKSerruysPWFour-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trialEurointervention201271060106121959320
  • OrmistonJASerruysPWOnumaYFirst serial assessment at 6 months and 2 years of the second generation of ABSORB everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyCirc Cardiovasc Interv2012562063223048057
  • SerruysPWChevalierBDudekDA bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialLancet2015385435425230593
  • CutlipDEWindeckerSMehranRClinical end points in coronary stent trials: a case for standardized definitionsCirculation20071152344235117470709
  • CutlipDEBaimDSHoKKStent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trialsCirculation20011031967197111306525
  • IakovouISchmidtTBonizzoniEIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsJAMA20052932126213015870416
  • WenaweserPReyCEberliFRStent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcomeEur Heart J2005261180118715728650
  • StoneGWMosesJWEllisSGSafety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsN Engl J Med2007356998100817296824
  • EisensteinELAnstromKJKongDFClopidogrel use and long-term clinical outcomes after drug-eluting stent implantationJAMA200729715916817148711
  • KastratiAMehilliJPacheJAnalysis of 14 trials comparing sirolimus-eluting stents with bare-metal stentsN Engl J Med20073561030103917296823
  • PopmaJJWeinerBCowleyMJSimontonCMcCormickDFeldmanTFDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendationsJ Interv Cardiol20072042544618042048
  • BaberUMehranRSharmaSKImpact of the everolimus-eluting stent on stent-thrombosis: a meta-analysis of 13 randomized trialsJ Am Coll Cardiol2011581569157721924575
  • PalmeriniTKirtaneAJSerruysPWStent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trialsCirc Cardiovasc Interv2012535736422668554
  • RaberLMagroMStefaniniGGVery late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort studyCirculation20121251110112122302840
  • von BirgelenCBasalusMWTandjungKA randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trialJ Am Coll Cardiol2012591350136122341737
  • PalmeriniTBiondi-ZoccaiGDella RivaDStent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisLancet20123791393140222445239
  • NakanoMYahagiKOtsukaFCauses of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy studyJ Am Coll Cardiol2014632510252024768883
  • Van WerkumJWHeestermansAAZomerACPredictors of coronary stent thrombosis: the Dutch Stent Thrombosis RegistryJ Am Coll Cardiol2009531399140919371823
  • MauriLHsiehWHMassaroJMHoKKD’AgostinoRCutlipDEStent thrombosis in randomized clinical trials of drug-eluting stentsN Engl J Med20073561020102917296821
  • KuchulakantiPKChuWWTorgusonRCorrelates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stentsCirculation20061131108111316490815
  • GeLAiroldiFIakovouIClinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilationJ Am Coll Cardiol20054661362016098424
  • ParkSJKangSJVirmaniRNakanoMUedaYIn-stent neoatherosclerosis. A final common pathway of late stent failureJ Am Coll Cardiol2012592051205722651862
  • JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol20064819320216814667
  • VirmaniRGuagliumiGFarbALocalized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?Circulation200410970170514744976
  • TsimikasSDrug-eluting stents and late adverse clinical outcomes: lessons learned, lessons awaitedJ Am Coll Cardiol2006472112211516697332
  • TanabeKSerruysPWDegertekinMIncomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trialCirculation200511190090515710761
  • Chin-QueeSLHsuSHNguyen-EhrenreichKLEndothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatingsBiomaterials20103164865719822362
  • KimMSDeanLSIn-stent restenosisCardiovasc Ther20112919019820406239
  • KastratiASchomigAEleziSPredictive factors of restenosis after coronary stent placementJ Am Coll Cardiol199730142814369362398
  • KomatsuRUedaMNarukoTKojimaABeckerAENeointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analysesCirculation1998982242339697822
  • KastratiADibraAMehilliJPredictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stentsCirculation20061132293230016682614
  • BarlisPRegarESerruysPWAn optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-studyEur Heart J20103113914219933285
  • NakazawaGFinnAVVorpahlMLadichERKolodgieFDVirmaniRCoronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stentsJ Am Coll Cardiol20115739039821251578
  • HamburgerSAMcEverRPGmp-140 mediates adhesion of stimulated platelets to neutrophilsBlood1990755505541688717
  • McEverRPCummingsRDRole of PSGL-1 binding to selectins in leukocyte recruitmentJ Clin Invest1997100S97S1039413410
  • CapliceNMBunchTJStalboergerPGSmooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantationProc Natl Acad Sci U S A20031004754475912665618
  • SataMSaiuraAKunisatoAHematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosisNat Med2002840340911927948
  • MathewVGershBJWilliamsBAOutcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trialCirculation200410947648014732749
  • KobayashiYDe GregorioJKobayashiNStented segment length as an independent predictor of restenosisJ Am Coll Cardiol19993465165910483943
  • HongMKParkSWMintzGSIntravascular ultrasonic predictors of angiographic restenosis after long coronary stentingAm J Cardiol20008544144510728947
  • FarbAKolodgieFDHwangJYExtracellular matrix changes in stented human coronary arteriesCirculation200411094094715302784
  • KimuraTAbeKShizutaSLong-term clinical and angiographic follow-up after coronary stent placement in native coronary arteriesCirculation20021052986299112081992
  • FarbAHellerPFShroffSPathological analysis of local delivery of paclitaxel via a polymer-coated stentCirculation200110447347911468212
  • VirmaniRLiistroFStankovicGMechanism of late in-stent restenosis after implantation of a paclitaxel-derivate-eluting polymer stent system in humansCirculation20021062649265112438288
  • InoueKAbeKAndoKPathological analyses of long-term intracoronary Palmaz–Schatz stenting: is its efficacy permanent?Cardiovasc Pathol20041310911515033161
  • OtsukaFVorpahlMNakanoMPathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humansCirculation201412921122324163064
  • WeidingerFFMcLenachanJMCybulskyMIPersistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac arteryCirculation199081166716792139594
  • JonerMNakazawaGFinnAVEndothelial cell recovery between comparator polymer-based drug-eluting stentsJ Am Coll Cardiol20085233334218652940
  • LeeCWKangSJParkDWIntravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantationJ Am Coll Cardiol2010551936194220430265
  • McDanielMCEshtehardiPSawayaFJDouglasJSSamadyHContemporary clinical applications of coronary intravascular ultrasoundJ Am Coll Cardiol Intv2011411551167
  • NairAKubanBDTuzcuEMSchoenhagenPNissenSEVinceDGCoronary plaque classification with intravascular radiofrequency data analysisCirculation20021062200220612390948
  • KangSJMintzGSParkDWTissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysisAm J Cardiol20101061561156521094355
  • YamaguchiTTerashimaMAkasakaTSafety and feasibility of an intravascular optical coherence tomography image wire system in the clinical settingAm J Cardiol200810156256718307999
  • TearneyGJWaxmanSShishkovMThree-dimensional coronary artery microscopy by intracoronary optical frequency domain imagingJ Am Coll Cardiol Img2008175261
  • LeeSYShinDHMintzGOptical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosisEurointervention2013994595124384291
  • KawamoriHShiteJShinkeTThe ability of optical coherence tomography to monitor percutaneous coronary intervention: detailed comparison with intravascular ultrasoundJ Invasive Cardiol2010225455
  • HabaraMTerashimaMSuzukiTDetection of atherosclerotic progression with rupture of degenerated in-stent intima five years after bare-metal stent implantation using optical coherence tomographyJ Invasive Cardiol20092155255319805847
  • TakanoMYamamotoMInamiSAppearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomographyJ Am Coll Cardiol200955263220117359
  • KangSJMintzGSAkasakaTOptical coherent tomographic analysis of in-stent neo-atherosclerosis after drug-eluting stent implantationCirculation20111232913291521709070